SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000880771-17-000025
Filing Date
2017-03-03
Accepted
2017-03-03 16:04:18
Documents
8
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A scln-20160630x10qa.htm 10-Q/A 71485
2 EX-10.1 scln-20160630xex10_1.htm EX-10.1 1011330
3 EX-10.2 scln-20160630xex10_2.htm EX-10.2 32170
4 EX-10.3 scln-20160630xex10_3.htm EX-10.3 32245
5 EX-10.4 scln-20160630xex10_4.htm EX-10.4 21914
6 EX-10.5 scln-20160630xex10_5.htm EX-10.5 22789
7 EX-31.1 scln-20160630xex31_1.htm EX-31.1 14492
8 EX-31.2 scln-20160630xex31_2.htm EX-31.2 16093
  Complete submission text file 0000880771-17-000025.txt   1223551
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19825 | Film No.: 17663515
SIC: 2834 Pharmaceutical Preparations